Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Hawley

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Current Gene Therapy|July 12, 2002
Progress toward vector design for hematopoietic stem cell gene therapyR G Hawley
Stem Cells (Dayton, Ohio)|January 1, 1994
Hematopathology of interleukin 6-type cytokinesR G Hawley
International Journal of Cancer|December 11, 1995
Adhesion molecules involved in the binding of murine myeloma cells to bone marrow stromal elementsT Okada, R G Hawley
Blood|January 1, 1997
Interferon-beta interrupts interleukin-6-dependent signaling events in myeloma cellsL C Berger, R G Hawley
Cancer Research|June 1, 1995
Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xLM M Schwarze, R G Hawley
Journal of Cellular Physiology|December 1, 1990
Suppression of programmed death and G1 arrest in B-cell hybridomas by interleukin-6 is not accompanied by altered expression of immediate early response genesL A Sabourin, R G Hawley
Leukemia & Lymphoma|June 27, 1998
Growth control mechanisms in multiple myelomaR G Hawley, L C Berger
Gene|March 1, 1981
Molecular cloning of an immunoglobulin kappa constant gene from NZB mouseN Hozumi, R G Hawley, H Murialdo
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 9, 2001
Tetracycline-regulatable adenovirus vectors: pharmacologic properties and clinical potentialS Nakagawa, B Massie, R G Hawley
Blood|June 15, 1990
Long- and short-lived murine hematopoietic stem cell clones individually identified with retroviral integration markersB Capel, R G Hawley, B Mintz
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Current Gene Therapy|July 12, 2002
Progress toward vector design for hematopoietic stem cell gene therapyR G Hawley
Stem Cells (Dayton, Ohio)|January 1, 1994
Hematopathology of interleukin 6-type cytokinesR G Hawley
International Journal of Cancer|December 11, 1995
Adhesion molecules involved in the binding of murine myeloma cells to bone marrow stromal elementsT Okada, R G Hawley
Blood|January 1, 1997
Interferon-beta interrupts interleukin-6-dependent signaling events in myeloma cellsL C Berger, R G Hawley
Cancer Research|June 1, 1995
Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xLM M Schwarze, R G Hawley
Journal of Cellular Physiology|December 1, 1990
Suppression of programmed death and G1 arrest in B-cell hybridomas by interleukin-6 is not accompanied by altered expression of immediate early response genesL A Sabourin, R G Hawley
Leukemia & Lymphoma|June 27, 1998
Growth control mechanisms in multiple myelomaR G Hawley, L C Berger
Gene|March 1, 1981
Molecular cloning of an immunoglobulin kappa constant gene from NZB mouseN Hozumi, R G Hawley, H Murialdo
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 9, 2001
Tetracycline-regulatable adenovirus vectors: pharmacologic properties and clinical potentialS Nakagawa, B Massie, R G Hawley
Blood|June 15, 1990
Long- and short-lived murine hematopoietic stem cell clones individually identified with retroviral integration markersB Capel, R G Hawley, B Mintz
Pageof 9